Scientists Found a Hidden Alzheimer's Trigger and Shut It Down
Researchers at Indiana University discovered an enzyme called IDOL that drives Alzheimer's disease. By removing this enzyme from neurons, they dramatically reduced amyloid plaques and improved brain resilience, offering a potential new treatment target.
New Enzyme Target for Alzheimer's Treatment
Researchers at the Indiana University School of Medicine have identified a potential new way to treat Alzheimer's disease by targeting an enzyme in the brain called IDOL. In laboratory studies, removing the enzyme from neurons significantly reduced amyloid plaques, one of the main biological hallmarks of Alzheimer's, and may also help the brain better resist damage linked to the disease.
Key Findings
Enzyme targets amyloid plaques: Removing the enzyme from neurons significantly reduced amyloid plaques and improved key brain processes linked to resilience.
Supporting neural health: Researchers found increased levels of receptors involved in regulating APOE and amyloid plaques after the enzyme was removed from neurons. These receptors are important for maintaining healthy communication between neurons and supporting lipid metabolism.